SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Lexicon Pharmaceuticals Q2 EPS $(0.65) Misses $(0.61) Estimate, Sales $9.16M Beat $8.83M Estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.61) by 6.56 percent. This is a 195.45 percent decrease over losses of $(0.22) per

Benzinga · -
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.61) by 6.56 percent. This is a 195.45 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $9.16 million which beat the analyst consensus estimate of $8.83 million by 3.77 percent. This is a 5.36 percent decrease over sales of $9.68 million the same period last year.